Cargando…
Methotrexate pneumonitis in a patient with gestational trophoblastic neoplasia
Methotrexate, an immunomodulatory agent used for a wide variety of indications, can cause pulmonary toxicity in the form of pneumonitis, organising pneumonia, pulmonary fibrosis, pleural effusion, pulmonary infections or lymphoproliferative disease. We report a case of methotrexate pneumonitis in a...
Autores principales: | Agarwal, M, Sharma, K K, Deokar, K, Bharti, N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
South African Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632629/ https://www.ncbi.nlm.nih.gov/pubmed/36339108 http://dx.doi.org/10.7196/AJTCCM.2022.v28i3.254 |
Ejemplares similares
-
Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia
por: Agarwal, R, et al.
Publicado: (2012) -
Spontaneous regression of gestational trophoblastic neoplasia
por: Niimi, Kaoru, et al.
Publicado: (2017) -
Dysgerminoma Masquerading as Gestational Trophoblastic Neoplasia
por: Blackwell, Conner, et al.
Publicado: (2023) -
Conservative management of uterine rupture in gestational trophoblastic neoplasia
por: David-West, Gizelka, et al.
Publicado: (2020) -
Differences in Administration of Methotrexate and Impact on Outcome in Low-Risk Gestational Trophoblastic Neoplasia
por: Wallin, Emelie, et al.
Publicado: (2022)